- News & Analysis
Page 1009
Safeguard gains from Clarient sale
GE Healthcare will pay about $580m for Safeguard Scientifics-backed Clarient at $5 per common share and $20 per preferred share.
Oct 24, 2010Dicerna takes funding to $50m
SR One backs B round extension for Dicerna Pharmaceuticals.
Oct 22, 2010Cerenis closes C round at $70m
French investors back C round extension for Cerenis Therapeutics.
Oct 22, 2010Ambit gains equity support
MedImmune, Roche and Genechem previously backed Ambit Biosciences, which is nearly to closing latest round.
Oct 21, 2010Burrill goes far to strike Infinity venture
Burrill and Infinity to co-invest as equal partners in US dollar and RMB investments in China.
Oct 17, 2010GE's Karen rides into Hewitt EnnisKnupp
Karen Rode becomes head of global private equity at Hewitt EnnisKnupp having previously been co-head of the $200m GE Healthymagination corporate venturing fund.
Oct 17, 2010Noxxon continues fundraising injections
US-based venture capital firm CD Ventures provides further $2m for Germany-based Noxxon Pharma.
Oct 13, 2010About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
© 2026 Mawsonia Ltd. All rights reserved.test regLogin